News for Galena Biopharma Inc - Google Finance

Galena Biopharma Now Covered by Analysts at JMP Securities (GALE)

Wed, 22 May 2013 11:18:58 GMT

Galena Biopharma Now Covered by Analysts at JMP Securities (GALE)
Mideast Time - 8 hours ago

Galena Biopharma, Inc. (NASDAQ: GALE), formerly RXi Pharmaceuticals Corporation, is a biotechnology company focused on discovering, developing and commercializing therapies addressing unmet medical needs using RNAi-targeted and ...

Galena Biopharma Inc. (NASDAQ:GALE) Up 6.77%, MannKind Corporation ...

Mon, 29 Apr 2013 16:11:17 GMT

Galena Biopharma Inc. (NASDAQ:GALE) Up 6.77%, MannKind Corporation ...
GSPInsider - Apr 29, 2013

Northern, WI 04/29/2013 (GDPInsider) - Galena Biopharma Inc. (NASDAQ:GALE) is up 6.77% having opened trading at $2.55. The stock has closed previously at $2.54 and has a range today of $2.54 and $2.74 on volume of 1.79 million.

Stocks Poised For A Potential Breakout: Goff Corp (OTCBB:GOFF), Galena ... - NIS

Biocare Decliners Stock Watch List: Galena Biopharma, Inc. (NASDAQ:GALE ...

Tue, 14 May 2013 12:47:00 GMT

Biocare Decliners Stock Watch List: Galena Biopharma, Inc. (NASDAQ:GALE ...
SBWire (press release) - May 14, 2013

Biocare Decliners Stock Watch List: Galena Biopharma, Inc. (NASDAQ:GALE), Affymax, Inc. (NASDAQ:AFFY), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), and Endo Health Solutions Inc. (NASDAQ:ENDP) Added to Growing Stock Report's Biocare ...

Stocks to Watch: Galena Biopharma Inc, Zagg Inc (NASDAQ:ZAGG), ARMOUR ...

Tue, 14 May 2013 13:41:20 GMT

Stocks to Watch: Galena Biopharma Inc, Zagg Inc (NASDAQ:ZAGG), ARMOUR ...
SBWire (press release) - May 14, 2013

Galena Biopharma Inc (NASDAQ:GALE) shares decreased 4.46% to $2.57. The company on May 9 reported its financial results for the quarter ended March 31, 2013 and provided a business update.

MannKind Corporation (NASDAQ:MNKD) trades flat, Galena Biopharma Inc ... - NIS

Galena Biopharma Poster Presentation at the American Pain Society 32nd ...

Thu, 09 May 2013 11:10:00 GMT

Galena Biopharma Poster Presentation at the American Pain Society 32nd ...
NASDAQ (press release) - May 9, 2013

LAKE OSWEGO, Ore., May 9, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (Nasdaq:GALE), a biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, ...

VIDEO RELEASE -- Galena Biopharma Reports First Quarter 2013 Financial ... - GlobeNewswire (press release)

NOVAVAX, INC. : MannKind, Ariad Pharma, Ziopharm Oncology, Galena ...

Tue, 23 Apr 2013 12:27:52 GMT

NOVAVAX, INC. : MannKind, Ariad Pharma, Ziopharm Oncology, Galena ...
4-traders (press release) - Apr 23, 2013

... the biotechnology sector yesterday were MannKind Corporation (NASDAQ: MNKD), Ariad Pharmaceuticals Inc. (NASDAQ: ARIA), ZIOPHARM Oncology Inc. (NASDAQ: ZIOP), Galena Biopharma Inc. (NASDAQ: GALE), and Novavax Inc. (NASDAQ: NVAX).

NASDAQ Gainers Watch List: Galena Biopharma, Inc. (NASDAQ:GALE) and ...

Tue, 07 May 2013 18:35:55 GMT

NASDAQ Gainers Watch List: Galena Biopharma, Inc. (NASDAQ:GALE) and ...
SBWire (press release) - May 7, 2013

Galena Biopharma, Inc. (NASDAQ:GALE) a biopharmaceutical company that focuses on developing oncology treatments to address major unmet medical needs to advance cancer care is currently up (+1.44%) on 1,903,022 shares traded.

Stocks in Focus (Galena Biopharma Inc, Renren Inc, Entravision Communication ...

Tue, 07 May 2013 13:25:56 GMT

Stocks in Focus (Galena Biopharma Inc, Renren Inc, Entravision Communication ...
SBWire (press release) - May 7, 2013

Galena Biopharma Inc (NASDAQ:GALE) shares increased 11.69% to $2.77. The company on May 1 announced the addition of William L. Ashton to the Company's Board of Directors.

Watch List: Galena Biopharma Inc (NASDAQ:GALE), Barrick Gold Corporation ...

Fri, 10 May 2013 17:46:14 GMT

Watch List: Galena Biopharma Inc (NASDAQ:GALE), Barrick Gold Corporation ...
Cogo - May 10, 2013

Galena Biopharma Inc (NASDAQ:GALE) shares decreased 1.47% to $2.69. The company on May 9 reported its financial results for the quarter ended March 31, 2013 and provided a business update.

Galena Biopharma (GALE): Timing is Still Everything

Wed, 01 May 2013 16:25:14 GMT

Galena Biopharma (GALE): Timing is Still Everything
SmallCap Network - May 1, 2013

April was, in simplest terms, a great one for Galena Biopharma Inc. (NASDAQ:GALE) and its investors. Shares of GALE ran from a close of $2.10 at the end of March to a close of $2.87 at the end of April... a 36% rally. As they say though, all good ...

Galena Biopharma Acquires Abstral Sublingual Tablets - Pain Medicine News